These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 78915)

  • 21. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
    Check JH; Brady LW; Leipold PL; O'Neill EA
    Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
    Srinivasa Rao V; Bonavida B
    Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observations on lymphomagenesis and lymphoma in AKR mice. A description of prelymphoma changes in the thymus and phenotypic diversity of lymphomas induced by SL3-3 virus.
    Hays EF; Bristol G
    Thymus; 1992 Jun; 19(4):219-34. PubMed ID: 1385666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of B cell lymphomas derived from thymectomized AKR mice expressing TL.4 antigen.
    Peled A; Haran-Ghera N
    J Exp Med; 1985 Sep; 162(3):1081-6. PubMed ID: 3897447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Analysis of the escape of tumor P1798(SC) from immunologic control in hybrid mice (Balb/c X AKR)F1 (BAF1)].
    Ubeira FM; Seoane R; Puentes E; Faro J; Regueiro BJ
    Rev Esp Oncol; 1982; 29(4):711-6. PubMed ID: 6985427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
    Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
    Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 32. The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes.
    Del Vellano BC; Nave B; Croker BP; Lerner RA; Dixon FJ
    J Exp Med; 1975 Jan; 141(1):172-87. PubMed ID: 46909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active immunoprophylaxis and immunotherapy in two mouse lymphoma models.
    Ghose T; Guclu A; Tai J; Norvell ST; MacDonald AS
    J Natl Cancer Inst; 1976 Aug; 57(2):303-15. PubMed ID: 794497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors.
    Mathieson BJ; Campbell PS; Potter M; Asofsky R
    J Exp Med; 1978 Apr; 147(4):1267-79. PubMed ID: 306411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of a distinctive differentiating antigen of activated mouse T- and B-lymphocytes--AKA-1].
    Nesterenko VG; Novikova TK; Fontalin LN; Vekhnik E; Rubakova EI
    Biull Eksp Biol Med; 1980 Oct; 90(10):449-51. PubMed ID: 6968597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of T-cell precursors in nude mice demonstrated by immunofluorescence of T-cell membrane markers.
    Loor F; Kindred B
    J Exp Med; 1973 Nov; 138(5):1044-55. PubMed ID: 4583069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural anti-tumor serum reactivity in BALB/c mice. I. Characterization and interference with tumor growth.
    Ménard S; Colnaghi MI; Porta GD
    Int J Cancer; 1977 Feb; 19(2):267-74. PubMed ID: 300077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.